Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

265
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
265
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

280
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
280
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

2.6K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.2K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

143
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
143
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

1.2K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticancer potential of phytochemicals derived from mangrove plants: Comprehensive mechanistic insights.

Food science & nutrition·2024
Same author

Recent Insights into the Antimicrobial Properties of Phyllanthus emblica L.: A Comprehensive Review of Wonder Berry.

Chemistry & biodiversity·2024
Same author

Assessment of Quercetin Antiemetic Properties: In Vivo and In Silico Investigations on Receptor Binding Affinity and Synergistic Effects.

Plants (Basel, Switzerland)·2023
Same author

Molecular Docking and ADME-TOX Profiling of <i>Moringa oleifera</i> Constituents against SARS-CoV-2.

Advances in respiratory medicine·2023
Same author

Anxiolytic-<i>like</i> Effects by <i>trans</i>-Ferulic Acid Possibly Occur through GABAergic Interaction Pathways.

Pharmaceuticals (Basel, Switzerland)·2023
Same author

Hirsutine, an Emerging Natural Product with Promising Therapeutic Benefits: A Systematic Review.

Molecules (Basel, Switzerland)·2023

Related Experiment Video

Updated: Dec 25, 2025

A Rapid and Specific Microplate Assay for the Determination of Intra- and Extracellular Ascorbate in Cultured Cells
11:56

A Rapid and Specific Microplate Assay for the Determination of Intra- and Extracellular Ascorbate in Cultured Cells

Published on: April 11, 2014

13.8K

Angiostatic effects of ascorbic acid: current status and future perspectives.

Muhammad Torequl Islam1

  • 1Department of Pharmacy, Life Science Faculty, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, 8100, Gopalganj, Bangladesh. dmt.islam@bsmrstu.edu.bd.

Angiogenesis
|April 3, 2020
PubMed
Summary

Ascorbic acid (AA) shows anti-angiogenesis effects in various test systems, suggesting its potential as an angiostatic agent for cancer treatment. Further research is needed to confirm its therapeutic efficacy.

Keywords:
AngiogenesisAscorbic acidCancer

More Related Videos

Generation of Self-assembled Vascularized Human Skin Equivalents
09:04

Generation of Self-assembled Vascularized Human Skin Equivalents

Published on: February 12, 2021

7.1K
Production of Modified Autologous Conditioned Serum and Ex Vivo Assessment of Its Healing Potential in Murine Corneal Epithelium
03:55

Production of Modified Autologous Conditioned Serum and Ex Vivo Assessment of Its Healing Potential in Murine Corneal Epithelium

Published on: March 24, 2023

2.4K

Related Experiment Videos

Last Updated: Dec 25, 2025

A Rapid and Specific Microplate Assay for the Determination of Intra- and Extracellular Ascorbate in Cultured Cells
11:56

A Rapid and Specific Microplate Assay for the Determination of Intra- and Extracellular Ascorbate in Cultured Cells

Published on: April 11, 2014

13.8K
Generation of Self-assembled Vascularized Human Skin Equivalents
09:04

Generation of Self-assembled Vascularized Human Skin Equivalents

Published on: February 12, 2021

7.1K
Production of Modified Autologous Conditioned Serum and Ex Vivo Assessment of Its Healing Potential in Murine Corneal Epithelium
03:55

Production of Modified Autologous Conditioned Serum and Ex Vivo Assessment of Its Healing Potential in Murine Corneal Epithelium

Published on: March 24, 2023

2.4K

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • The anti-angiogenesis effect of ascorbic acid (AA) remains a subject of scientific debate.
  • Existing evidence indicates that AA exhibits anti-angiogenic properties across diverse biological models.

Discussion:

  • This paper reviews scientific data supporting the anti-angiogenesis role of AA.
  • The findings suggest AA's potential utility in inhibiting tumor blood vessel formation.

Key Insights:

  • Ascorbic acid demonstrates anti-angiogenesis effects in animal models, human subjects, and cell lines.
  • The evidence points towards AA's capacity to impede the development of new blood vessels.

Outlook:

  • Ascorbic acid presents a promising avenue as an angiostatic agent for cancer therapy.
  • Further clinical investigations are warranted to validate AA's therapeutic potential in oncology.